D6567

DRF 2519

≥98% (HPLC), solid

• 동의어(들): 5-[[4-[2-(4-Oxo-2H-1,3-benzoxazin3(4H)-yl)ethoxy]phenyl]methyl2,4-thiazolidinedione
• 실험식(Hill 표기법): C₂₀H₁₈N₂O₅S
• Molecular Weight: 398.43
• MDL number: MFCD06798336
• UNSPSC 코드: 12352200
• PubChem Substance ID: 24894036

속성

• 분석: ≥98% (HPLC)
• 형태: solid
• 저장 조건: under inert gas
• 색상: white
• solubility: DMSO: ≥10 mg/mL
• 저장 온도: 2-8°C
• SMILES string: O=C1NC(=O)C(Cc2ccc(OCCN3COc4ccccc4C3=O)cc2)S1

설명

생화학적/생리학적 작용

DRF-2519 is a dual PPARα/γ activator. DRF-2519 has better reduction of plasma insulin, triglyceride, and free fatty acid levels than those treated with rosiglitazone.

안전성 정보

• Storage Class Code: 13 - Non Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable
• 개인 보호 장비: Eyeshields, Gloves, type N95 (US)